Adverum Biotechnologies/ US00773U2078 /
| 6/16/2025 9:59:47 PM | Chg. +0.01 | Volume | Bid9:59:48 PM | Ask9:59:48 PM | High | Low |
|---|---|---|---|---|---|---|
| 2.46USD | +0.41% | 3,089 Turnover: 7,527.92 |
2.46Bid Size: 200 | 2.48Ask Size: 100 | 2.48 | 2.41 |
GlobeNewswire
6/5
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
5/14
Adverum Biotechnologies Reports First Quarter 2025 Financial Results and Provides Pipeline Highlight...
GlobeNewswire
5/9
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnolo...
GlobeNewswire
5/5
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnolo...
GlobeNewswire
5/2
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
4/29
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnolo...
GlobeNewswire
4/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnolo...
GlobeNewswire
4/21
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnolo...
GlobeNewswire
4/17
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnolo...
GlobeNewswire
4/15
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pip...
GlobeNewswire
4/12
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnolo...
GlobeNewswire
4/4
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
4/4
Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee
GlobeNewswire
3/31
Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Confere...
GlobeNewswire
3/3
Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD
GlobeNewswire
2/28
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
2/25
Adverum Biotechnologies to Participate in the Cowen 45th Annual Health Care Conference
GlobeNewswire
2/5
Adverum Biotechnologies to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Confe...
GlobeNewswire
8/12/2024
Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corpo...
GlobeNewswire
8/2/2024
Adverum Biotechnologies to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Confe...
GlobeNewswire
8/1/2024
Adverum Biotechnologies Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Gran...
GlobeNewswire
7/24/2024
Emerging Gene Therapies Signal Transformative Shift in Retinal Disorder Treatment, According to Sphe...
